InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Henrik Krook, Dirigeant. Officer active across 1 companies, notably Egetis Therapeutics AB (publ). Cumulatively, 2 reports have been logged. The latest transaction was filed on 11 May 2026 (Purchase). Regulator: FIN-FSA. The full history is openly available.
Declarations2 total
0264,880 shares0
Aktie
FI:A003Y615-1·
Ideal exit: 5 Feb 2027 (T+270)
€8,92925,000 shares@ €0.35720.0004% mcap100.0% of flow
Aktie
FI:A003U240-1·
Ideal exit: 23 Aug 2026 (T+270)
2 of 2 declarations
About Henrik Krook
Henrik Krook is a member of the administration of Egetis Therapeutics AB (publ). He is involved in strategic decision-making and oversight of the company's operations.
